752 POSTER Gemcitabine plus oxaliplatin (GEMOX) in advanced hepatocellular carcinoma (HCC): results of a phase II study

首页> 外文期刊>European Journal of Cancer Supplements >752 POSTER Gemcitabine plus oxaliplatin (GEMOX) in advanced hepatocellular carcinoma (HCC): results of a phase II study

【24h】

752 POSTER Gemcitabine plus oxaliplatin (GEMOX) in advanced hepatocellular carcinoma (HCC): results of a phase II study

机译：752 POSTER吉西他滨加奥沙利铂（GEMOX）治疗晚期肝细胞癌（HCC）：II期研究的结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2005年第2期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 3540 POSTER Postoperative adjuvant gemcitabine plus oxaliplatin (GemOx) chemotherapy followed by chemoradiation in patients with pancreatic carcinoma: mature results of a multicenter phase II study [J] . F.Mornex, T.Andre, C.Louvet, European Journal of Cancer Supplements . 2007,第4期

机译：3540 POSTER胰腺癌患者术后吉西他滨联合奥沙利铂（GemOx）化疗后放化疗：多中心II期研究的成熟结果
2. Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study. [J] . Asnacios A, Fartoux L, Romano O, Cancer: A Journal of the American Cancer Society . 2008,第12期

机译：吉西他滨加奥沙利铂（GEMOX）联合西妥昔单抗治疗进展期晚期肝细胞癌：一项多中心2期研究的结果。
3. A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract. [J] . Theodore C, Bidault F, Bouvet Forteau N, Annals of oncology: official journal of the European Society for Medical Oncology . 2006,第6期

机译：奥沙利铂联合吉西他滨（GEMOX）在尿路上皮晚期/转移性移行细胞癌（TCC）患者中的II期单中心研究。
4. The Application of Lipidomics to the Study of Hepatocellular Carcinoma (HCC) Induced by Low Dose, High-Energy, High Charge Ions (HZE) [C] . Brooke L. Barnette, Shinji K. Strain, Cheryl F. Lichti, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：脂类物学在低剂量，高能量，高电荷离子（HZE）诱导肝细胞癌（HCC）研究中的应用
5. Baseline Toronto HCC Risk Index (THRI) and Albumin Predict Low Risk of Hepatocellular Carcinoma (HCC) after Sustained Virological Response (SVR) in HCV Infection [D] . Lau, Jason. 2019

机译：基线多伦多HCC风险指数（THRI）和白蛋白预测HCV感染持续病毒响应（SVR）后肝细胞癌（HCC）的低风险
6. Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study [O] . A Demols, M Peeters, M Polus, 2006

机译：吉西他滨难治性晚期胰腺腺癌的吉西他滨和奥沙利铂（GEMOX）：II期研究
7. Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study [O] . Demols, A, Peeters, M, Polus, M, 2006

机译：吉西他滨难治性晚期胰腺腺癌的吉西他滨和奥沙利铂（GEMOX）：II期研究

752 POSTER Gemcitabine plus oxaliplatin (GEMOX) in advanced hepatocellular carcinoma (HCC): results of a phase II study

著录项

相似文献

相关主题

期刊订阅